Reporting quality of randomized controlled trials in patients with HIV on antiretroviral therapy: a systematic review

被引:6
作者
Nagai, Kaori [1 ,2 ]
Saito, Akiko M. [2 ]
Saito, Toshiki I. [2 ]
Kaneko, Noriyo [1 ]
机构
[1] Nagoya City Univ, Grad Sch Nursing, Dept Global & Community Hlth, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan
[2] Natl Hosp Org, Clin Res Ctr, Dept Clin Res Management, Naka Ku,Nagoya Med Ctr, 4-1-1 Sannomaru, Nagoya, Aichi 4600001, Japan
关键词
HIV/AIDS; ART; Randomized controlled trials; CONSORT; Reporting quality; INHIBITOR THERAPY; INFORMED-CONSENT; CLINICAL-TRIALS; ADHERENCE; HAART;
D O I
10.1186/s13063-017-2360-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: To allow for correct evaluation of clinical trial results, readers require comprehensive, clear, and highly transparent information on the methodology used and the results obtained. This study aimed to evaluate the quality of reporting in articles on randomized controlled trials (RCTs) of antiretroviral therapy (ART) in the field of HIV/AIDS. Methods: We searched for original articles on RCTs of ART developed in the field of HIV/AIDS in PubMed database by 5 April 2016. Searched articles were divided into three groups based on the revision year in which the Consolidated Standards of Reporting Trials (CONSORT) guidelines were published: Period 1 (1996-2001); Period 2 (2002-2010); and Period 3 (2011-2016). We evaluated the articles using the reporting rates of the 37 items in the CONSORT 2010 checklist, five items in the protocol deviation, and the three items in the ethics. Results: Fifty-two articles were extracted and included in this study. Many of the reporting rates calculated using the CONSORT 2010 checklist showed a significantly increasing trend over the successive periods (65% in Period 1, 67% in Period 2, 79% in Period 3; p < 0.0001). The items with reporting rates < 50% were "the presence or absence of a protocol change and the reason for such a change," "randomization and blinding," and "where the full trial protocol can be accessed." Reporting rates of deviations were as low as < 30%, while the reporting rates for patient compliance were the highest (>80% in Period 3) among the five items. The reporting rates for obtaining informed consent and approval by the ethics committee or institutional review board were high (>88%), regardless of the time period assessed. Conclusion: In terms of representative RCT articles in the field of HIV/AIDS, the reporting rate of the items defined by CONSORT was approximately 70%, improving over the successive CONSORT statement revision periods.
引用
收藏
页数:12
相关论文
共 25 条
[1]   A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment [J].
Andrade, ASA ;
McGruder, HF ;
Wu, AW ;
Celano, SA ;
Skolasky, RL ;
Selnes, OA ;
Huang, IC ;
McArthur, JC .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (06) :875-882
[2]  
[Anonymous], JAP OFF DEV ASS WHIT
[3]  
[Anonymous], GUIDELINES USE ANTIR
[4]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[5]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[6]   Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine [J].
Cahn, P ;
Vibhagool, A ;
Schechter, M ;
Soto-Ramirez, L ;
Carosi, G ;
Smaill, F ;
Jordan, JC ;
Pharo, CE ;
Thomas, NE ;
Steele, HM .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (07) :1115-1123
[7]   Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review [J].
Chowers, Michal Y. ;
Gottesman, Bat Sheva ;
Leibovici, Leonard ;
Pielmeier, Ulrike ;
Andreassen, Steen ;
Paul, Mical .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) :239-250
[8]  
Cocohoba Jennifer, 2014, Int J Pharm Pract, V22, P375, DOI 10.1111/ijpp.12096
[9]   Deficient Reporting and Interpretation of Non-Inferiority Randomized Clinical Trials in HIV Patients: A Systematic Review [J].
Hernandez, Adrian V. ;
Pasupuleti, Vinay ;
Deshpande, Abhishek ;
Thota, Priyaleela ;
Collins, Jaime A. ;
Vidal, Jose E. .
PLOS ONE, 2013, 8 (05)
[10]  
HUTH EJ, 1988, BRIT MED J, V296, P401